Serum concentration of asprosin in new-onset type 2 diabetes

Serum concentration of asprosin in new-onset type 2 diabetes

Abstract Background Asprosin, a newly identified adipokine, is pathologically increased in individuals with insulin resistance. However, the available evidence on the association of asprosin and type 2 diabetes mellitus (T2DM) status is still scarce. Therefore, this study aimed to determine the rela...

Full description

Bibliographic Details
Main Authors: Shakiba Naiemian, Mohsen Naeemipour, Mehdi Zarei, Moslem Lari Najafi, Ali Gohari, Mohammad Reza Behroozikhah, Hafez Heydari, Mohammad Miri
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Diabetes mellitus
Asprosin
Adipokine
Insulin resistance
Online Access:http://link.springer.com/article/10.1186/s13098-020-00564-w

Internet

http://link.springer.com/article/10.1186/s13098-020-00564-w

Similar Items